An Intervention to Improve Outcomes in Patients With Advanced Cancer

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01272024

Acronym

TEAMS

Enrollment

146

Registered

2011-01-07

Start date

2009-09-30

Completion date

2013-08-31

Last updated

2016-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

clinical trial, symptom education, advanced cancer

Brief summary

1.) To integrate discharge planning into an intervention provided by advanced practice nurses (APRNs)for patients with advanced cancer, 2.) To evaluate the effects of the intervention, and 3.) To explore the reach, adoption, and implementation of the intervention to facilitate the transition of patients from surgery/biopsy/chemotherapy to medical oncology in a comprehensive cancer center.

Interventions

BEHAVIORALSymptom Education

Participants are given a Symptom Education Toolkit at baseline and at each visit thereafter (1 month and 3 month) are encouraged to use the Toolkit for symptoms they are experiencing. They are also encouraged to use resources available to them.

BEHAVIORALIntervention

Participants are visited/contacted by an intervention nurse ten times over a 12-week period for the purpose of helping them to manage uncertainty and distress,to boost their problem-solving skills, and to transition to treatment.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

21 Years to No maximum

Healthy volunteers

Inclusion criteria

* primary diagnosis of advanced lung, GI, Head & Neck, and Lung cancers * post-surgical/or post-biopsy with physician's order for cancer treatment * age 21 years or older * lives within 50 of Yale New Haven Hospital * has 2 or more co-morbid conditions * has an emotional distress thermometer score of greater than or equal to 4-

Design outcomes

Primary

Measure	Time frame	Description
Uncertainty	1 month post baseline	The MUIS-C contains 23 Likert scale items with scores that range from 1= strongly disagree to 5= strongly agree.

Secondary

Measure	Time frame	Description
HADS- Anxiety	1 month post baseline	7 items are rated on a 4-point scale.
HADS-Anxiety	3 months post baseline.	7 items are rated on a 4-point scale.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026